Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.6.0.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
COSTS AND EXPENSES:    
Research and development $ 4,750,414 $ 5,158,874
General and administrative 4,699,338 3,395,360
Restructuring costs 0 203,631
Total costs and expenses 9,449,752 8,757,865
LOSS FROM OPERATIONS (9,449,752) (8,757,865)
OTHER INCOME (EXPENSE):    
Gain on revaluation of derivative warrants 3,261,529 3,667,826
Loss on issuance of derivative warrants 0 (404,150)
Interest income (expense), net 7,897 (841)
Total other income, net 3,269,426 3,262,835
NET LOSS $ (6,180,326) $ (5,495,030)
BASIC AND DILUTED NET LOSS PER COMMON SHARE $ (1.36) $ (7.03)
SHARES USED IN COMPUTING BASIC AND DILUTED NET LOSS PER COMMON SHARE 4,536,563 781,975